UCSF Recognized for Trial of the Year

The Society of Clinical Trials has named UCSF's Management of Myelomeningocele Study (MOMS), a review of prenatal versus postnatal surgery for myelomengingocele (spina bifida), as its Trial of the Year. The study earned recognition as an important clinical trial that overcame difficulties and produced remarkable results.